Biomerica Inc Cash Flow Conversion Efficiency
Biomerica Inc cash flow conversion efficiency. Based on the latest financial reports, Biomerica Inc (BMRA) has a cash flow conversion efficiency ratio of -0.347x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-912.00K) by net assets ($2.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Biomerica Inc (1989–2026)
Cash flow conversion efficiency of Biomerica Inc from 1989 to 2026. This chart illustrates how Biomerica Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BMRA stock price for real-time trading data and today's change.
Biomerica Inc Cash Flow Conversion Ratio Explained
Biomerica Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Biomerica Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biomerica Inc ranked by their cash flow conversion efficiency. Also see Biomerica Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
2020 Bulkers Ltd.
F:0FF
|
0.104x |
|
Cerberus Cyber Sentinel Corp
NASDAQ:CISO
|
-0.006x |
|
Augros Cosmetic Packaging SA
PA:AUGR
|
-0.287x |
|
Manhattan Corporation Limited
F:32U
|
-0.016x |
|
BioLine RX Ltd
TA:BLRX
|
-0.193x |
|
Akbar Indomakmur Stimec Tbk
JK:AIMS
|
1.357x |
|
ZHONGLIANG HLDG HD-01
F:3ZH
|
N/A |
|
Visgeneer
TWO:4197
|
-0.062x |
Annual Cash Flow Conversion Efficiency for Biomerica Inc (1989–2026)
The table below shows the annual cash flow conversion efficiency of Biomerica Inc from 1989 to 2026. Review BMRA FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-05-31 | $2.63 Million | $-3.42 Million | -1.301x | -39.02% |
| 2025-05-31 | $4.11 Million | $-3.84 Million | -0.936x | -15.04% |
| 2024-05-31 | $6.59 Million | $-5.36 Million | -0.813x | -74.21% |
| 2023-05-31 | $11.72 Million | $-5.47 Million | -0.467x | -708.86% |
| 2022-05-31 | $8.32 Million | $-480.53K | -0.058x | +89.86% |
| 2021-05-31 | $9.23 Million | $-5.25 Million | -0.569x | -88.24% |
| 2020-05-31 | $14.21 Million | $-4.30 Million | -0.302x | +46.36% |
| 2019-05-31 | $3.98 Million | $-2.24 Million | -0.564x | -107.66% |
| 2018-05-31 | $4.33 Million | $-1.17 Million | -0.271x | -68.57% |
| 2017-05-31 | $4.49 Million | $-722.86K | -0.161x | -302.63% |
| 2016-05-31 | $5.22 Million | $-208.78K | -0.040x | +44.76% |
| 2015-05-31 | $5.60 Million | $-405.48K | -0.072x | +50.34% |
| 2014-05-31 | $5.91 Million | $-862.27K | -0.146x | -161.02% |
| 2013-05-31 | $5.83 Million | $1.39 Million | 0.239x | +706.88% |
| 2012-05-31 | $4.98 Million | $147.41K | 0.030x | -61.00% |
| 2011-05-31 | $4.33 Million | $328.80K | 0.076x | +230.18% |
| 2010-05-31 | $4.06 Million | $-236.98K | -0.058x | -148.64% |
| 2009-05-31 | $4.35 Million | $-102.00K | -0.023x | +53.18% |
| 2008-05-31 | $3.88 Million | $-194.59K | -0.050x | -118.94% |
| 2007-05-31 | $1.75 Million | $463.71K | 0.265x | +173.07% |
| 2006-05-31 | $1.06 Million | $-385.17K | -0.362x | -1854.28% |
| 2005-05-31 | $3.53 Million | $72.92K | 0.021x | +196.65% |
| 2004-05-31 | $3.51 Million | $-75.03K | -0.021x | -113.52% |
| 2003-05-31 | $3.25 Million | $512.54K | 0.158x | +497.02% |
| 2002-05-31 | $3.30 Million | $-131.07K | -0.040x | -228.48% |
| 2001-05-31 | $3.52 Million | $108.95K | 0.031x | +105.93% |
| 2000-05-31 | $4.91 Million | $-2.56 Million | -0.522x | -709.72% |
| 1999-05-31 | $6.20 Million | $-400.00K | -0.065x | -200.00% |
| 1998-05-31 | $6.20 Million | $400.00K | 0.065x | -45.62% |
| 1997-05-31 | $5.90 Million | $700.00K | 0.119x | -2.71% |
| 1996-05-31 | $4.10 Million | $500.00K | 0.122x | -21.95% |
| 1995-05-31 | $3.20 Million | $500.00K | 0.156x | -48.44% |
| 1994-05-31 | $3.30 Million | $1.00 Million | 0.303x | +312.12% |
| 1993-05-31 | $2.80 Million | $-400.00K | -0.143x | +17.86% |
| 1992-05-31 | $2.30 Million | $-400.00K | -0.174x | -139.53% |
| 1991-05-31 | $2.50 Million | $1.10 Million | 0.440x | +1112.00% |
| 1990-05-31 | $4.60 Million | $-200.00K | -0.043x | +76.09% |
| 1989-05-31 | $3.30 Million | $-600.00K | -0.182x | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more